Release Date: 29/04/16 09:28 Summary: Quarterly Cashflow Report-BRB.AX Price Sensitive: Yes Download Document 100.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%